Nicotinamide Riboside Shows Promise in Treating Peripheral Artery Disease

Discover the latest breakthrough in treating peripheral artery disease (PAD) with nicotinamide riboside. A recent clinical trial showed significant improvement in walking endurance for PAD patients taking this vitamin B3 supplement. Learn more about the promising results and future plans for larger trials in this article.